Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Actavis Closes $28B Forest Deal, Names New CEO

By Pharmaceutical Processing | July 1, 2014

Actavis has completed its $28 billion acquisition of fellow drugmaker Forest Laboratories, and the leader of the acquired company is now the CEO of Actavis.

The Ireland-based drugmaker said Tuesday that Brenton L. Saunders will serve as Actavis president and CEO. Former Actavis Chairman and CEO Paul M. Bisaro, who helped shepherd the company through several multibillion dollar acquisitions, will become executive chairman.

Actavis Plc had announced the cash-and-stock acquisition in February, when it was initially valued at about $25 billion. Actavis said then that Bisaro would lead the combined company.

But three months later, the drugmakers said Bisaro would move to the newly created position of executive chairman, and Saunders would take over as CEO. Actavis said the appointments reflect the complementary expertise of management teams from both companies and the increased size and complexity of the combined business.

Saunders had served as Forest Laboratories Inc. CEO for less than a year. Before that, he led optical products maker Bausch & Lomb Inc., which was acquired by Valeant Pharmaceuticals International Inc.

Actavis also added two Forest Labs board members, Dr. Nesli Basgoz and Christopher J. Coughlin, to its board.

Actavis shares climbed $3 to $226.07 in Tuesday morning trading, while the Standard & Poor’s 500 index rose less than 1 percent.

Related Articles Read More >

Pfizer logo
Pfizer seeks to comply with voluntary Net-Zero Standard by 2040
Fujifilm Diosynth Technologies
Fujifilm to spend $1.6B to bolster cell culture manufacturing services
Wyzo
Wyzo high-speed pick-and-place sidebot wins design awards
Purdue University
Purdue University launches institute for advanced manufacturing of pharmaceuticals

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards